For healthcare professionals only

Letters Vitamin D deficiency

Authors’ reply to Nussey

BMJ 2013; 346 doi: (Published 19 February 2013) Cite this as: BMJ 2013;346:f964
  1. P Arundel, consultant in paediatric metabolic bone disease and secretary of British Paediatric and Adolescent Bone Group 1,
  2. S F Ahmed, Samson Gemmell chair of child health2,
  3. J Allgrove, consultant paediatric endocrinologist3,
  4. N J Bishop, professor of paediatric bone disease 4,
  5. C P Burren, consultant paediatric endocrinologist and diabetologist 5,
  6. B Jacobs, consultant paediatrician6,
  7. M Z Mughal, consultant in paediatric bone disorders7,
  8. A C Offiah, Higher Education Funding Council for England clinical senior lecturer4,
  9. N J Shaw, consultant paediatric endocrinologist8
  1. 1Sheffield Children’s NHS Foundation Trust, Sheffield, UK
  2. 2School of Medicine, University of Glasgow, Glasgow, UK
  3. 3Great Ormond Street Hospital, London, UK
  4. 4Academic Unit of Child Health, University of Sheffield, Sheffield, UK
  5. 5Bristol Royal Hospital for Children, Bristol, UK
  6. 6Royal National Orthopaedic Hospital, Stanmore, UK
  7. 7Royal Manchester Children’s Hospital, Manchester, UK
  8. 8Birmingham Children’s Hospital, Birmingham, UK
  1. p.arundel{at}

We read Professor Nussey’s response to our position statement with interest.1 2 We are not a committee but a current comprehensive group of clinicians who manage children with bone disease in the UK. Our opinions are based on our combined clinical experience of vitamin D deficiency in infants, children, and adolescents across the UK. Our statement was a concise expression of our position rather than an exposition of the evidence. However, careful consideration of the extant literature underpins our statement (although we acknowledge the paucity of studies that examine clinical outcomes in …

View Full Text

Log in

Log in through your institution


* For online subscription